Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05307874
Title Phase 1/2a Study of ICT01 Plus Low Dose SC IL-2 in Patients With Advanced Solid Tumors (EVICTION-2)
Recruitment Recruiting
Phase Phase Ib/II
Variant Requirements No
Sponsors ImCheck Therapeutics

colorectal cancer

prostate cancer

ovarian cancer

pancreatic ductal adenocarcinoma


Aldesleukin + ICT01

Age Groups: senior | adult
Covered Countries FRA

No variant requirements are available.